Article Information
History
- August 2, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Jochen G. Mainz1,2,†,*,
- Anton Barucha1,2,†,
- Pu Huang1,2,
- Lilith Bechinger1,2,
- Franziska Duckstein1,2,
- Louise Polte1,2,
- Pauline Sadrieh1,2,
- Lutz Nährlich3,
- Olaf Eickmeier4,
- Suzanne van Dullemen4,
- Patience Eschenhagen5,
- Carsten Schwarz5,
- Stefan Lüth6,
- Carlos Zagoya1,2,# and
- Ute Graepler-Mainka7,#
- 1CF-Center, Klinikum Westbrandenburg, Campus Brandenburg an der Havel, Germany
- 2Medizinische Hochschule Brandenburg (MHB), Universitätsklinikum, Brandenburg an der Havel, Germany
- 3CF Center for Children Justus-Liebig-Universität Gießen, Universitätsklinikum Gießen-Marburg GmbH, Germany
- 4Division of Allergy, Pulmonology and Cystic Fibrosis, Department for Children and Adolescents, University Hospital, Frankfurt, Germany
- 5CF-Center, Klinikum Westbrandenburg, Campus Potsdam, Germany
- 6Department of Gastroenterology, Brandenburg Medical School (Theodor Fontane), Brandenburg an der Havel, Germany
- 7Children’s Hospital, Eberhard-Karls-University, Tübingen, Germany
- ↵*Correspondence: Prof. Dr. Jochen G. Mainz j.mainz{at}klinikum-brandenburg.de
↵# These authors contributed equally to this work and share last authorship
Posted August 02, 2023.
Dynamics of abdominal symptoms during the start of a new therapy with Elexacaftor/Tezacaftor/Ivacaftor using the novel CFAbd-day2day questionnaire
